Latest Patents News

Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.

Firebrick Pharma expanded its patent portfolio with grants in Canada and New Zealand while achieving 43% sales growth in FY26 despite steady operating expenses. The company is advancing Nasodine's commercial rollout across Southeast Asia and the US.

Syntara secured positive FDA feedback for its Phase 2b amsulostat trial in myelofibrosis and raised $8 million to extend its cash runway to Q3 2027, while preliminary data showed promising brain inflammation reduction in a Parkinson’s-related disorder.

BlinkLab has bolstered its war chest with a A$17.5 million placement, secured a foundational US patent valid through 2041, and made significant progress in its FDA autism diagnostic trial and European ADHD study.

Nyrada has dosed the first patient in its Phase IIa trial of Xolatryp targeting heart attack recovery, while strengthening its cash reserves and receiving a US patent allowance for its lead drug.

Patrys Limited is pushing forward with a proprietary injectable formulation of quetiapine targeting the lucrative delirium treatment market, leveraging a faster, lower-cost FDA 505(b)(2) regulatory pathway and strong patent protection.

Orbital Corporation's 150HFE propulsion system has powered its inaugural flight on AATI's AiRanger UAV, triggering follow-on orders worth over US$750,000 and signalling growth in UAV propulsion sales and service revenue.

Diablo Resources has acquired an 80% stake in the historic Horn Silver Project, complementing its nearby Star Range assets and advancing exploration with a maiden drill program approved.

Latrobe Magnesium (ASX: LMG) is set for leadership change with Robert Stein stepping in as CEO from October 2026, while Peter Mizera takes charge of the Construction Committee, underpinning the company’s push towards magnesium metal production.

Dimerix has strengthened its kidney disease pipeline with a US patent grant for DMX-652, extending protection until 2043 and setting the stage for a Phase 2 trial targeting acute kidney injury after cardiac surgery.

Nico Resources has completed preparations for a key infill drilling campaign at its Wingellina nickel-cobalt project, aiming to upgrade resource classifications and refine metallurgical understanding. The company also inked a strategic MOU with Pure Battery Technologies to explore regional refining opportunities amid a turbulent nickel price environment.

Ardea Resources pushes back the completion of its Kalgoorlie Nickel Project DFS to pursue optimisation opportunities, while securing strong multi-level government backing and maintaining a robust financial position.